Literature DB >> 6148907

Clinical pharmacology of vecuronium and atracurium.

R D Miller, S M Rupp, D M Fisher, R Cronnelly, M R Fahey, Y J Sohn.   

Abstract

Vecuronium and atracurium provide addition flexibility to the clinician using neuromuscular blocking drugs. The shorter duration of action, lack of significant cardiovascular effects, and the lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available nondepolarizing neuromuscular blocking drugs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148907     DOI: 10.1097/00000542-198410000-00014

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  19 in total

1.  Continuous infusion of vecuronium in children.

Authors:  H Obara; H Hoshina; O Tanaka; R Chuma; H Kaetsu; N Maekawa; S Iwai
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

2.  Quantitative determination of atracurium in human plasma using high-performance liquid chromatography.

Authors:  R Okutani; K Kono; F M DeBros; D M Philbin
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

Review 3.  Drug interactions with neuromuscular blockers.

Authors:  S Feldman; L Karalliedde
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

4.  Neuromuscular blockade with vecuronium in paediatric patients with burn injury.

Authors:  A K Mills; J A Martyn
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

5.  Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation.

Authors:  L S Bluestein; L W Stinson; R L Lennon; S N Quessy; R M Wilson
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

6.  Antiestrogenic drugs and atracurium--a possible interaction?

Authors:  M Naguib; H K Gyasi
Journal:  Can Anaesth Soc J       Date:  1986-09

Review 7.  Intravenous anaesthetic agents. Pharmacokinetic-pharmacodynamic relationships.

Authors:  B N Swerdlow; F O Holley
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

8.  A comparative evaluation of intubating doses of atracurium, d-tubocurarine, pancuronium and vecuronium in children.

Authors:  C J Montgomery; D J Steward
Journal:  Can J Anaesth       Date:  1988-01       Impact factor: 5.063

9.  Vecuronium neuromuscular block in patients with malignant obstructive jaundice.

Authors:  A Baraka
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

10.  Difference in the effect of pancuronium and vecuronium on baroreflex control of heart rate in humans.

Authors:  H Tsuchida; S Seki; Y Nakae; A Namiki
Journal:  J Anesth       Date:  1991-07       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.